Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses -10 K10 K00010 K 10 K Research & development —————— — Operating income -70.88 K-265.01 K-240.94 K-405.81 K-873.51 K-2.19 M -3.71 M Non-Operating Income, Total 2.99 M2.7 M2.73 M2.76 M2.58 M2.37 M 10.45 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 2.99 M2.7 M2.73 M2.76 M2.58 M2.37 M 10.45 M Unusual income/expense —————— — Pretax income 2.92 M2.43 M2.49 M2.36 M1.71 M180.5 K 6.74 M Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 2.92 M2.43 M2.49 M2.36 M1.71 M180.5 K 6.74 M Discontinued operations —————— — Net income 2.92 M2.43 M2.49 M2.36 M1.71 M180.5 K 6.74 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 2.92 M2.43 M2.49 M2.36 M1.71 M180.5 K 6.74 M Basic earnings per share (Basic EPS) —0.320.320.28-0.360.04 0.28 Diluted earnings per share (Diluted EPS) 0.460.320.320.28-0.360.04 0.28 Average basic shares outstanding 5.82 M63.25 M63.25 M63.25 M31.63 M52.6 M — Diluted shares outstanding 6.33 M63.25 M63.25 M63.25 M31.63 M52.6 M — EBITDA —————— — EBIT -721-33.45 K-26.42 K-29.16 K-29.53 K-39.57 K -124.68 K Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) —————— —